Clinical Trials
6 trialsNCT03564548 2021-07-28
REBORN
Tetra Bio-Pharma
Phase 2 Unknown
NCT01824524 2014-08-15
A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer
Xian-Janssen Pharmaceutical Ltd.
Phase 1 Completed
NCT01205126 2014-02-03
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3 Completed
NCT00766831 2013-10-23
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown